UK:
Genomic Medicine: Regulating Clinical Pathways
To print this article, all you need is to be registered or login on Mondaq.com.
While genomic medicine is a growing area of interest, and
genetic and genomic tests are being used more and more widely
across UK NHS clinical specialities, challenges relating to
governance and regulation of genomic clinical services still exist.
Consultant Cliodhna McDonough shares her views on genomic medicine
and regulatory issues which require further analysis with Pharma
Times.
Click here to read the article.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from UK
Elderly Care FAQ
Wrigleys Solicitors
These FAQs cover topics related to caring for elderly relatives. It discusses how to place an elderly person in a care home, the absence of legal obligation for family members to provide long-term care...
Food Law | UK Regulatory Outlook March 2024
Osborne Clarke
Scotland launches consultation on stricter HFSS restrictions | FSA launch campaign on allergy risks with vegan labelling | Consultation launched on fairer food labelling...